| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Myriad Genetics, Inc., Salt Lake City, Utah 84108 [D. H-F. T., W. L. P., M. B., R. B., S. B., T. D., D. F., C. F., T. H., R. H., S. J., T. J., A. L., J. T. M., R. P., D. S., M. S., P-H. S., B. S., P. B., A. K. C. W., A. O., A. T., M. H. S., S. V. T.], and Department of Medicine, Massachusetts General Hospital, Diabetes Unit and Medical Services, and Harvard Medical School, Boston Massachusetts 02129 [J. K. H., J. M. K., J. A.]
Mitogen-activated protein kinases function in signal transduction pathways that are involved in controlling key cellular processes in many organisms. A mammalian member of this kinase family, MKK4/JNKK1/SEK1, has been reported to link upstream MEKK1 to downstream stress-activated protein kinase/JNK1 and p38 mitogen-activated protein kinase. This mitogen-activated protein kinase pathway has been implicated in the signal transduction of cytokine- and stress-induced apoptosis in a variety of cell types. Here, we report that two human tumor cell lines, derived from pancreatic carcinoma and lung carcinoma, harbor homozygous deletions that eliminate coding portions of the MKK4 locus at 17p, located approximately 10 cM centromeric of p53. In addition, in a set of 88 human cancer cell lines prescreened for loss of heterozygosity, we detected two nonsense and three missense sequence variants of MKK4 in cancer cell lines derived from human pancreatic, breast, colon, and testis cells. In vitro biochemical assays revealed that, when stimulated by MEKK1, four of the five altered MKK4 proteins lacked the ability to phosphorylate stress-activated protein kinase. Thus, the incidence of coding mutations of MKK4 in the set of cell lines is 6 of 213 (
3%). These findings suggest that MKK4 may function as a suppressor of tumorigenesis or metastasis in certain types of cells.
1 These authors are equal contributors.
2 To whom requests for reprints should be addressed, at Myriad Genetic, Inc., 390 Wakara Way, Salt Lake City, UT 84108. Phone: (801) 584-3676; Fax: (801) 584-3650; E-mail: tengd@myriad.com.
Received 7/ 7/97. Accepted 8/13/97.
This article has been cited by other articles:
![]() |
V. L. Robinson, O. Shalhav, K. Otto, T. Kawai, M. Gorospe, and C. W. Rinker-Schaeffer Mitogen-Activated Protein Kinase Kinase 4/c-Jun NH2-Terminal Kinase Kinase 1 Protein Expression Is Subject to Translational Regulation in Prostate Cancer Cell Lines Mol. Cancer Res., March 1, 2008; 6(3): 501 - 508. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Gorringe, S. Jacobs, E. R. Thompson, A. Sridhar, W. Qiu, D. Y.H. Choong, and I. G. Campbell High-Resolution Single Nucleotide Polymorphism Array Analysis of Epithelial Ovarian Cancer Reveals Numerous Microdeletions and Amplifications Clin. Cancer Res., August 15, 2007; 13(16): 4731 - 4739. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Sethi, K. S. Ahn, D. Xia, J. M. Kurie, and B. B. Aggarwal Targeted Deletion of MKK4 Gene Potentiates TNF-Induced Apoptosis through the Down-Regulation of NF-{kappa}B Activation and NF-{kappa}B-Regulated Antiapoptotic Gene Products J. Immunol., August 1, 2007; 179(3): 1926 - 1933. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Sanchez-Tillo, M. Comalada, J. Xaus, C. Farrera, A. F. Valledor, C. Caelles, J. Lloberas, and A. Celada JNK1 Is Required for the Induction of Mkp1 Expression in Macrophages during Proliferation and Lipopolysaccharide-dependent Activation J. Biol. Chem., April 27, 2007; 282(17): 12566 - 12573. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Xia, H. Srinivas, Y.-h. Ahn, G. Sethi, X. Sheng, W. K. A. Yung, Q. Xia, P. J. Chiao, H. Kim, P. H. Brown, et al. Mitogen-activated Protein Kinase Kinase-4 Promotes Cell Survival by Decreasing PTEN Expression through an NF{kappa}B-dependent Pathway J. Biol. Chem., February 9, 2007; 282(6): 3507 - 3519. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-Y. Wang, M. Iordanov, and Q. Zhang c-Jun NH2-terminal Kinase Promotes Apoptosis by Down-regulating the Transcriptional Co-repressor CtBP J. Biol. Chem., November 17, 2006; 281(46): 34810 - 34815. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Cunningham, F. Kamangar, M. P. Kim, S. Hammoud, R. Haque, C. Iacobuzio-Donahue, R. Ashfaq, S. E. Kern, A. Maitra, R. E. Heitmiller, et al. MKK4 Status Predicts Survival After Resection of Gastric Adenocarcinoma Arch Surg, November 1, 2006; 141(11): 1095 - 1099. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Calhoun, T. Hucl, E. Gallmeier, K. M. West, D. E. Arking, A. Maitra, C. A. Iacobuzio-Donahue, A. Chakravarti, R. H. Hruban, and S. E. Kern Identifying Allelic Loss and Homozygous Deletions in Pancreatic Cancer without Matched Normals Using High-Density Single-Nucleotide Polymorphism Arrays Cancer Res., August 15, 2006; 66(16): 7920 - 7928. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Cunningham, E. Gallmeier, T. Hucl, D. A. Dezentje, E. S. Calhoun, G. Falco, K. Abdelmohsen, M. Gorospe, and S. E. Kern Targeted Deletion of MKK4 in Cancer Cells: A Detrimental Phenotype Manifests as Decreased Experimental Metastasis and Suggests a Counterweight to the Evolution of Tumor-Suppressor Loss Cancer Res., June 1, 2006; 66(11): 5560 - 5564. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gioeli, B. E. Black, V. Gordon, A. Spencer, C. T. Kesler, S. T. Eblen, B. M. Paschal, and M. J. Weber Stress Kinase Signaling Regulates Androgen Receptor Phosphorylation, Transcription, and Localization Mol. Endocrinol., March 1, 2006; 20(3): 503 - 515. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Cunningham, F. Kamangar, M. P. Kim, S. Hammoud, R. Haque, C. A. Iacobuzio-Donahue, A. Maitra, R. Ashfaq, S. Hustinx, R. E. Heitmiller, et al. Claudin-4, mitogen-activated protein kinase kinase 4, and stratifin are markers of gastric adenocarcinoma precursor lesions. Cancer Epidemiol. Biomarkers Prev., February 1, 2006; 15(2): 281 - 287. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Vander Griend, M. Kocherginsky, J. A. Hickson, W. M. Stadler, A. Lin, and C. W. Rinker-Schaeffer Suppression of Metastatic Colonization by the Context-Dependent Activation of the c-Jun NH2-Terminal Kinase Kinases JNKK1/MKK4 and MKK7 Cancer Res., December 1, 2005; 65(23): 10984 - 10991. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Uhlirova, H. Jasper, and D. Bohmann Non-cell-autonomous induction of tissue overgrowth by JNK/Ras cooperation in a Drosophila tumor model PNAS, September 13, 2005; 102(37): 13123 - 13128. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Davies, C. Hunter, R. Smith, P. Stephens, C. Greenman, G. Bignell, J. Teague, A. Butler, S. Edkins, C. Stevens, et al. Somatic Mutations of the Protein Kinase Gene Family in Human Lung Cancer Cancer Res., September 1, 2005; 65(17): 7591 - 7595. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-Y. Lee, S.-H. Oh, Y.-A. Suh, J. H. Baek, V. Papadimitrakopoulou, S. Huang, and W. K. Hong Response of Non-Small Cell Lung Cancer Cells to the Inhibitors of Phosphatidylinositol 3-Kinase/Akt- and MAPK Kinase 4/c-Jun NH2-Terminal Kinase Pathways: An Effective Therapeutic Strategy for Lung Cancer Clin. Cancer Res., August 15, 2005; 11(16): 6065 - 6074. [Abstract] [Full Text] [PDF] |
||||
![]() |
N Nathoo, A Chahlavi, G H Barnett, and S A Toms Pathobiology of brain metastases J. Clin. Pathol., March 1, 2005; 58(3): 237 - 242. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Xin, K. J. Yun, F. Ricci, M. Zahurak, W. Qiu, G. H. Su, C. J. Yeo, R. H. Hruban, S. E. Kern, and C. A. Iacobuzio-Donahue MAP2K4/MKK4 Expression in Pancreatic Cancer: Genetic Validation of Immunohistochemistry and Relationship to Disease Course Clin. Cancer Res., December 15, 2004; 10(24): 8516 - 8520. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Aguirre-Ghiso, L. Ossowski, and S. K. Rosenbaum Green Fluorescent Protein Tagging of Extracellular Signal-Regulated Kinase and p38 Pathways Reveals Novel Dynamics of Pathway Activation during Primary and Metastatic Growth Cancer Res., October 15, 2004; 64(20): 7336 - 7345. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. T. Ho, A. J. Bardwell, M. Abdollahi, and L. Bardwell A Docking Site in MKK4 Mediates High Affinity Binding to JNK MAPKs and Competes with Similar Docking Sites in JNK Substrates J. Biol. Chem., August 29, 2003; 278(35): 32662 - 32672. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-Y. Lee, H. Srinivas, D. Xia, Y. Lu, R. Superty, R. LaPushin, C. Gomez-Manzano, A. M. Gal, G. L. Walsh, T. Force, et al. Evidence That Phosphatidylinositol 3-Kinase- and Mitogen-activated Protein Kinase Kinase-4/c-Jun NH2-terminal Kinase-dependent Pathways Cooperate to Maintain Lung Cancer Cell Survival J. Biol. Chem., June 20, 2003; 278(26): 23630 - 23638. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Kennedy, H. K. Sluss, S. N. Jones, D. Bar-Sagi, R. A. Flavell, and R. J. Davis Suppression of Ras-stimulated transformation by the JNK signal transduction pathway Genes & Dev., March 1, 2003; 17(5): 629 - 637. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-Y. Lee, Y.-A. Suh, J. I. Lee, K. A. Hassan, L. Mao, T. Force, B. E. Gilbert, T. Jacks, and J. M. Kurie Inhibition of Oncogenic K-ras Signaling by Aerosolized Gene Delivery in a Mouse Model of Human Lung Cancer Clin. Cancer Res., September 1, 2002; 8(9): 2970 - 2975. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Murphy, K. A. Brune, C. Griffin, J. E. Sollenberger, G. M. Petersen, R. Bansal, R. H. Hruban, and S. E. Kern Evaluation of Candidate Genes MAP2K4, MADH4, ACVR1B, and BRCA2 in Familial Pancreatic Cancer: Deleterious BRCA2 Mutations in 17% Cancer Res., July 1, 2002; 62(13): 3789 - 3793. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-Q. Wu, H. Chen, M. A. Rubin, K. J. Wojno, and K. A. Cooney Loss of Heterozygosity of the Putative Prostate Cancer Susceptibility Gene HPC2/ELAC2 Is Uncommon in Sporadic and Familial Prostate Cancer Cancer Res., December 1, 2001; 61(24): 8651 - 8653. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Page, J. Li, and M. B. Hershenson p38 MAP kinase negatively regulates cyclin D1 expression in airway smooth muscle cells Am J Physiol Lung Cell Mol Physiol, May 1, 2001; 280(5): L955 - L964. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Westermarck, S.-P. Li, T. Kallunki, J. Han, and V.-M. Kähäri p38 Mitogen-Activated Protein Kinase-Dependent Activation of Protein Phosphatases 1 and 2A Inhibits MEK1 and MEK2 Activity and Collagenase 1 (MMP-1) Gene Expression Mol. Cell. Biol., April 1, 2001; 21(7): 2373 - 2383. [Abstract] [Full Text] |
||||
![]() |
H. L. Kim, D. J. Vander Griend, X. Yang, D. A. Benson, Z. Dubauskas, B. A. Yoshida, M. A. Chekmareva, Y. Ichikawa, M. H. Sokoloff, P. Zhan, et al. Mitogen-activated Protein Kinase Kinase 4 Metastasis Suppressor Gene Expression Is Inversely Related to Histological Pattern in Advancing Human Prostatic Cancers Cancer Res., April 1, 2001; 61(7): 2833 - 2837. [Abstract] [Full Text] |
||||
![]() |
J. A. Aguirre-Ghiso, D. Liu, A. Mignatti, K. Kovalski, and L. Ossowski Urokinase Receptor and Fibronectin Regulate the ERKMAPK to p38MAPK Activity Ratios That Determine Carcinoma Cell Proliferation or Dormancy In Vivo Mol. Biol. Cell, April 1, 2001; 12(4): 863 - 879. [Abstract] [Full Text] |
||||
![]() |
V. G. Gorgoulis, P. Zacharatos, G. Mariatos, T. Liloglou, S. Kokotas, N. Kastrinakis, A. Kotsinas, A. Athanasiou, P. Foukas, V. Zoumpourlis, et al. Deregulated Expression of c-mos in Non-Small Cell Lung Carcinomas: Relationship with p53 Status, Genomic Instability, and Tumor Kinetics Cancer Res., January 1, 2001; 61(2): 538 - 549. [Abstract] [Full Text] |
||||
![]() |
K. R. LaMontagne Jr., M. A. Moses, D. Wiederschain, S. Mahajan, J. Holden, H. Ghazizadeh, D. A. Frank, and J. L. Arbiser Inhibition of MAP Kinase Kinase Causes Morphological Reversion and Dissociation between Soft Agar Growth and in Vivo Tumorigenesis in Angiosarcoma Cells Am. J. Pathol., December 1, 2000; 157(6): 1937 - 1945. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. C. Wong, F. Shanahan, Y. Chen, L. Lian, P. Ha, K. Hendricks, S. Ghaffari, D. Iliev, B. Penn, A.-M. Woodland, et al. BRG1, a Component of the SWI-SNF Complex, Is Mutated in Multiple Human Tumor Cell Lines Cancer Res., November 1, 2000; 60(21): 6171 - 6177. [Abstract] [Full Text] |
||||
![]() |
M. Gekle, G. Schwerdt, R. Freudinger, S. Mildenberger, D. Wilflingseder, V. Pollack, M. Dander, and H. Schramek Ochratoxin A Induces JNK Activation and Apoptosis in MDCK-C7 Cells at Nanomolar Concentrations J. Pharmacol. Exp. Ther., June 1, 2000; 293(3): 837 - 844. [Abstract] [Full Text] |
||||
![]() |
C.-W. Wu, A. F.-Y. Li, C.-W. Chi, C. L. Huang, K.-H. Shen, W.-Y. Liu, and W.-c. Lin Human Gastric Cancer Kinase Profile and Prognostic Significance of MKK4 Kinase Am. J. Pathol., June 1, 2000; 156(6): 2007 - 2015. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yamano, H. Fujii, T. Takagaki, N. Kadowaki, H. Watanabe, and T. Shirai Genetic Progression and Divergence in Pancreatic Carcinoma Am. J. Pathol., June 1, 2000; 156(6): 2123 - 2133. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Yoshida, Z. Dubauskas, M. A. Chekmareva, T. R. Christiano, W. M. Stadler, and C. W. Rinker-Schaeffer Mitogen-activated Protein Kinase Kinase 4/Stress-activated Protein/Erk Kinase 1 (MKK4/SEK1), a Prostate Cancer Metastasis Suppressor Gene Encoded by Human Chromosome 17 Cancer Res., November 1, 1999; 59(21): 5483 - 5487. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Larsson, P. Klint, E. Landgren, and L. Claesson-Welsh Fibroblast Growth Factor Receptor-1-mediated Endothelial Cell Proliferation Is Dependent on the Src Homology (SH) 2/SH3 Domain-containing Adaptor Protein Crk J. Biol. Chem., September 3, 1999; 274(36): 25726 - 25734. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Bost, R. McKay, M. Bost, O. Potapova, N. M. Dean, and D. Mercola The Jun Kinase 2 Isoform Is Preferentially Required for Epidermal Growth Factor-Induced Transformation of Human A549 Lung Carcinoma Cells Mol. Cell. Biol., March 1, 1999; 19(3): 1938 - 1949. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Tournier, A. J. Whitmarsh, J. Cavanagh, T. Barrett, and R. J. Davis The MKK7 Gene Encodes a Group of c-Jun NH2-Terminal Kinase Kinases Mol. Cell. Biol., February 1, 1999; 19(2): 1569 - 1581. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Engel, M. Seifert, B. Theisinger, U. Seyfert, and C. Welter Glyceraldehyde-3-phosphate Dehydrogenase and Nm23-H1/Nucleoside Diphosphate Kinase A. TWO OLD ENZYMES COMBINE FOR THE NOVEL Nm23 PROTEIN PHOSPHOTRANSFERASE FUNCTION J. Biol. Chem., August 7, 1998; 273(32): 20058 - 20065. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |